Growth Metrics

Oscar Health (OSCR) Return on Equity (2020 - 2025)

Oscar Health (OSCR) has disclosed Return on Equity for 6 consecutive years, with 0.44% as the latest value for Q4 2025.

  • For the quarter ending Q4 2025, Return on Equity fell 47.0% year-over-year to 0.44%, compared with a TTM value of 0.44% through Dec 2025, down 47.0%, and an annual FY2025 reading of 0.44%, down 51.0% over the prior year.
  • Return on Equity was 0.44% for Q4 2025 at Oscar Health, up from 0.48% in the prior quarter.
  • Across five years, Return on Equity topped out at 162.32% in Q1 2024 and bottomed at 80531.0% in Q2 2025.
  • Average Return on Equity over 5 years is 4023.87%, with a median of 0.39% recorded in 2025.
  • The sharpest move saw Return on Equity surged 16355bps in 2024, then crashed -8042988bps in 2025.
  • Year by year, Return on Equity stood at 0.23% in 2021, then plummeted by -386bps to 1.12% in 2022, then surged by 48bps to 0.59% in 2023, then skyrocketed by 104bps to 0.02% in 2024, then plummeted by -1975bps to 0.44% in 2025.
  • Business Quant data shows Return on Equity for OSCR at 0.44% in Q4 2025, 0.48% in Q3 2025, and 80531.0% in Q2 2025.